Krutika Joshi, D.B.Sc., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antipsychotic Agents | 20 | 2022 | 3077 | 3.960 |
Why?
|
Nasal Sprays | 7 | 2024 | 27 | 2.920 |
Why?
|
Schizophrenia | 20 | 2022 | 6986 | 2.670 |
Why?
|
Depressive Disorder, Major | 22 | 2023 | 4816 | 2.610 |
Why?
|
Medicaid | 14 | 2024 | 2843 | 1.530 |
Why?
|
Ketamine | 4 | 2024 | 524 | 1.490 |
Why?
|
Antidepressive Agents | 16 | 2024 | 2913 | 1.460 |
Why?
|
Health Care Costs | 23 | 2023 | 3265 | 1.340 |
Why?
|
Medication Adherence | 8 | 2021 | 2190 | 1.310 |
Why?
|
Risperidone | 4 | 2019 | 383 | 1.220 |
Why?
|
Veterans | 5 | 2022 | 2671 | 0.920 |
Why?
|
Administration, Oral | 11 | 2021 | 4041 | 0.910 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2023 | 1097 | 0.870 |
Why?
|
Cisterna Magna | 1 | 2022 | 39 | 0.800 |
Why?
|
Insurance | 1 | 2023 | 115 | 0.780 |
Why?
|
United States | 35 | 2024 | 73121 | 0.620 |
Why?
|
Health Resources | 5 | 2019 | 950 | 0.580 |
Why?
|
Patient Acceptance of Health Care | 8 | 2023 | 3237 | 0.560 |
Why?
|
Cost of Illness | 8 | 2021 | 1960 | 0.510 |
Why?
|
Delayed-Action Preparations | 5 | 2021 | 969 | 0.490 |
Why?
|
Retrospective Studies | 32 | 2024 | 81834 | 0.480 |
Why?
|
Adult | 42 | 2024 | 223542 | 0.480 |
Why?
|
Community Mental Health Services | 1 | 2018 | 389 | 0.470 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4861 | 0.460 |
Why?
|
Insurance, Health | 5 | 2024 | 2513 | 0.440 |
Why?
|
Insurance Claim Review | 4 | 2021 | 745 | 0.410 |
Why?
|
Injections | 5 | 2018 | 840 | 0.400 |
Why?
|
Administration, Intranasal | 2 | 2024 | 485 | 0.370 |
Why?
|
Suicidal Ideation | 6 | 2023 | 1466 | 0.360 |
Why?
|
Substance-Related Disorders | 3 | 2023 | 4453 | 0.360 |
Why?
|
Middle Aged | 29 | 2024 | 223418 | 0.320 |
Why?
|
Medicare | 6 | 2022 | 6881 | 0.300 |
Why?
|
Male | 35 | 2024 | 364781 | 0.300 |
Why?
|
Depression | 7 | 2023 | 8235 | 0.290 |
Why?
|
Female | 36 | 2024 | 396943 | 0.280 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1677 | 0.280 |
Why?
|
Longitudinal Studies | 8 | 2020 | 14766 | 0.280 |
Why?
|
Humans | 48 | 2024 | 768451 | 0.250 |
Why?
|
Costs and Cost Analysis | 2 | 2022 | 1670 | 0.230 |
Why?
|
Recurrence | 3 | 2021 | 8510 | 0.230 |
Why?
|
Hospitalization | 7 | 2019 | 10845 | 0.200 |
Why?
|
Young Adult | 11 | 2024 | 60045 | 0.190 |
Why?
|
Veterans Health | 2 | 2022 | 215 | 0.190 |
Why?
|
Psychotic Disorders | 1 | 2016 | 3278 | 0.180 |
Why?
|
Bipolar Disorder | 1 | 2018 | 5124 | 0.180 |
Why?
|
Efficiency | 1 | 2022 | 477 | 0.160 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 557 | 0.150 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15638 | 0.140 |
Why?
|
Models, Econometric | 1 | 2018 | 215 | 0.140 |
Why?
|
Standard of Care | 1 | 2022 | 571 | 0.140 |
Why?
|
Drug Approval | 1 | 2024 | 817 | 0.140 |
Why?
|
Comorbidity | 4 | 2020 | 10601 | 0.140 |
Why?
|
Neck | 1 | 2022 | 736 | 0.140 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2017 | 303 | 0.140 |
Why?
|
Brain Stem | 1 | 2022 | 862 | 0.130 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5510 | 0.130 |
Why?
|
Pharmaceutical Services | 1 | 2017 | 143 | 0.130 |
Why?
|
Adolescent | 8 | 2023 | 89168 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5367 | 0.120 |
Why?
|
Anti-Anxiety Agents | 1 | 2017 | 405 | 0.120 |
Why?
|
Cohort Studies | 5 | 2024 | 41797 | 0.110 |
Why?
|
Spinal Cord | 1 | 2022 | 1814 | 0.110 |
Why?
|
Aged | 10 | 2024 | 171520 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2019 | 925 | 0.110 |
Why?
|
Long-Term Care | 1 | 2017 | 633 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1089 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 952 | 0.110 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1439 | 0.110 |
Why?
|
Cost Savings | 1 | 2017 | 916 | 0.100 |
Why?
|
Benzodiazepines | 1 | 2017 | 1139 | 0.090 |
Why?
|
Ambulatory Care | 2 | 2018 | 2780 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59680 | 0.080 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2754 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6537 | 0.080 |
Why?
|
Anxiety | 1 | 2023 | 4655 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5096 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4096 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2391 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39430 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18478 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10647 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12561 | 0.060 |
Why?
|
Bupropion | 1 | 2023 | 304 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13497 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26351 | 0.050 |
Why?
|
Prevalence | 3 | 2021 | 15880 | 0.040 |
Why?
|
Absenteeism | 1 | 2021 | 247 | 0.040 |
Why?
|
Medicare Part C | 1 | 2024 | 332 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2024 | 7863 | 0.040 |
Why?
|
Drug Interactions | 1 | 2021 | 1421 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1643 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 921 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.030 |
Why?
|
Brain | 1 | 2022 | 27438 | 0.030 |
Why?
|
Mice | 1 | 2022 | 82045 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 8081 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2731 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2020 | 685 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 54914 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2017 | 65409 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2561 | 0.020 |
Why?
|
Animals | 1 | 2022 | 169418 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3471 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.020 |
Why?
|
Incidence | 1 | 2021 | 21552 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7956 | 0.010 |
Why?
|
Mental Disorders | 1 | 2018 | 6879 | 0.010 |
Why?
|